Current understanding of the pathogenesis and management of chronic recurrent multifocal osteomyelitis

Current Rheumatology Reports

Volumn 14, Issue 2, 2012, Pages 130-141

  Ferguson, Polly J ^a   Sandu, Monica ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

Biologic agents; Biphosphonates; Bone disease; Bone pain; Children; Chronic nonbacterial osteomyelitis; Chronic recurrent multifocal osteomyelitis; CNO; CRMO; DIRA; Majeed syndrome; Management; NSAIDs; Osteomyelitis; Pathogenesis; SAPHO syndrome; Sweet's syndrome; Vertebrae

Indexed keywords

ADALIMUMAB; ANTIBIOTIC AGENT; AZITHROMYCIN; BISPHOSPHONIC ACID DERIVATIVE; COLCHICINE; CORTICOSTEROID; CYCLOSPORIN; DAPSONE; ETANERCEPT; ETRETINATE; GAMMA INTERFERON; INFLIXIMAB; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; ISOTRETINOIN; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NAPROXEN; NONSTEROID ANTIINFLAMMATORY AGENT; PAMIDRONIC ACID; PREDNISONE; PSORALEN; RECOMBINANT INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; SALAZOSULFAPYRIDINE; TUMOR NECROSIS FACTOR INHIBITOR;

ACNE; ACUTE FEBRILE NEUTROPHILIC DERMATOSIS; AORTA ARCH SYNDROME; ARTHRITIS; CELIAC DISEASE; CHRONIC OSTEOMYELITIS; CHRONIC RECURRENT MULTIFOCAL OSTEOMYELITIS; CLINICAL FEATURE; CONGENITAL DYSERYTHROPOIETIC ANEMIA; CROHN DISEASE; DERMATOMYOSITIS; DISEASE ASSOCIATION; ENCHONDROMATOSIS; GENE MUTATION; GENETIC SUSCEPTIBILITY; GENETICS; HUMAN; LIVER PARENCHYMA; LUNG DISEASE; MAJEED SYNDROME; NONHUMAN; OSTEITIS; OUTCOME ASSESSMENT; PATHOGENESIS; PATHOPHYSIOLOGY; PROTEIN DEFICIENCY; PSORIASIS VULGARIS; PUSTULOSIS; PUSTULOSIS PALMOPLANTARIS; PYODERMA GANGRENOSUM; RADIOLOGY; REVIEW; SCLEROSING CHOLANGITIS; SINGLE DRUG DOSE; TUMOR CALCINOSIS; ULCERATIVE COLITIS; VASCULITIS;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; DIPHOSPHONATES; HUMANS; OSTEOMYELITIS; RECURRENCE;

EID: 84860833889     PISSN: 15233774     EISSN: 15346307     Source Type: Journal    
DOI: 10.1007/s11926-012-0239-5     Document Type: Review

References (97)

1. Jansson A, Renner ED, Ramser J, Mayer A, Haban M, Meindl A, Grote V, Diebold J, Jansson V, Schneider K, Belohradsky BH. Classification of non-bacterial osteitis: retrospective study of clinical, immunological and genetic aspects in 89 patients. Rheumatol (Oxford). 2007;46:154-60. (Pubitemid 44932805)
2. Girschick HJ, Raab P, Surbaum S, Trusen A, Kirschner S, Schneider P, Papadopoulos T, Muller-Hermelink HK, Lipsky PE. Chronic non-bacterial osteomyelitis in children. Ann Rheum Dis. 2005;64:279-85. (Pubitemid 40193627)
3. El-Shanti HI, Ferguson PJ. Chronic recurrent multifocal osteomyelitis: a concise review and genetic update. Clin Orthop Relat Res. 2007;462:11-9. (Pubitemid 47367837)
4. Schultz C, Holterhus PM, Seidel A, Jonas S, Barthel M, Kruse K, Bucsky P. Chronic recurrent multifocal osteomyelitis in children. Pediatr Infect Dis J. 1999;18:1008-13.
5. Huber AM, Lam PY, Duffy CM, Yeung RS, Ditchfield M, Laxer D, Cole WG, Kerr Graham H, Allen RC, Laxer RM. Chronic recurrent multifocal osteomyelitis: clinical outcomes after more than five years of follow-up. J Pediatr. 2002;141:198-203.
6. • Khanna G, Sato TS, Ferguson P. Imaging of chronic recurrent multifocal osteomyelitis. Radiographics. 2009;29:1159-77. This article provides comprehensive examples of the various radiologic manifestations of CRMO.
7. •• Hofmann SR, Schwarz T, Moller JC, Morbach H, Schnabel A, Rosen-Wolff A, Girschick HJ, Hedrich CM. Chronic nonbacterial osteomyelitis is associated with impaired Sp1 signaling, reduced IL10 promoter phosphorylation, and reduced myeloid IL-10 expression. Clin Immunol. 2011;141:317-27. This article presents data that implicate IL-10 dysregulation in disease pathogenesis.
8. Girschick HJ, Huppertz HI, Harmsen D, Krauspe R, Muller- Hermelink HK, Papadopoulos T. Chronic recurrent multifocal osteomyelitis in children: diagnostic value of histopathology and microbial testing. Hum Pathol. 1999;30:59-65. (Pubitemid 29037395)
9. Jurik AG, Egund N. MRI in chronic recurrent multifocal osteomyelitis. Skeletal Radiol. 1997;26:230-8. (Pubitemid 27197062)
10. Bjorksten B, Gustavson KH, Eriksson B, Lindholm A, Nordstrom S. Chronic recurrent multifocal osteomyelitis and pustulosis palmoplantaris. J Pediatr. 1978;93:227-31. (Pubitemid 8380033)
11. Sasaki T. A case of osteomyelitis of the bilateral clavicles associated with pustulosis palmaris et plantaris. Rinsho Seikeigeka. 1967;2:333-7.
12. Paller AS, Pachman L, Rich K, Esterly NB, Gonzalez-Crussi F. Pustulosis palmaris et plantaris: its association with chronic recurrent multifocal osteomyelitis. J Am Acad Dermatol. 1985;12:927-30. (Pubitemid 15052578)
13. Kawai K, Doita M, Tateishi H, Hirohata K. Bone and joint lesions associated with pustulosis palmaris et plantaris. A clinical and histological study. J Bone Joint Surg Br. 1988;70:117-22. (Pubitemid 18059173)
14. Bergdahl K, Bjorksten B, Gustavson KH, Liden S, Probst F. Pustulosis palmoplantaris and its relation to chronic recurrent multifocal osteomyelitis. Dermatologica. 1979;159:37-45. (Pubitemid 9220638)
15. Laxer RM, Shore AD, Manson D, King S, Silverman ED, Wilmot DM. Chronic recurrent multifocal osteomyelitis and psoriasis-a report of a new association and review of related disorders. Semin Arthritis Rheum. 1988;17:260-70.
16. Schilling F, Marker-Hermann E. Chronic recurrent multifocal osteomyelitis in association with chronic inflammatory bowel disease: entheropathic CRMO. Z Rheumatol. 2003;62:527-38. (Pubitemid 38121889)
17. Bazrafshan A, Zanjani KS. Chronic recurrent multifocal osteomyelitis associated with ulcerative colitis: a case report. J Pediatr Surg. 2000;35:1520-2.
18. Jo Y, Matsumoto T, Nagamine R. A case of Crohn's disease with leg pain. Br J Radiol. 2001;74:203-4. (Pubitemid 32249052)
19. Bognar M, Blake W, Agudelo C. Chronic recurrent multifocal osteomyelitis associated with Crohn's disease. Am J Med Sci. 1998;315:133-5. (Pubitemid 28090577)
20. Bousvaros A, Marcon M, Treem W, Waters P, Issenman R, Couper R, Burnell R, Rosenberg A, Rabinovich E, Kirschner BS. Chronic recurrent multifocal osteomyelitis associated with chronic inflammatory bowel disease in children. Dig Dis Sci. 1999;44:2500-7. (Pubitemid 30027368)
21. Carpenter E, Jackson MA, Friesen CA, Scarbrough M, Roberts CC. Crohn's-associated chronic recurrent multifocal osteomyelitis responsive to infliximab. J Pediatr. 2004;144:541-4. (Pubitemid 38457363)
22. Kahn MF, Bouchon JP, Chamot AM, Palazzo E. Chronic enterocolopathies and SAPHO syndrome. 8 cases. Rev Rhum Mal Osteoartic. 1992;59:91-4.
23. Prose NS, Fahrner LJ, Miller CR, Layfield L. Pustular psoriasis with chronic recurrent multifocal osteomyelitis and spontaneous fractures. J Am Acad Dermatol. 1994;31:376-9. (Pubitemid 24249270)
24. •• Aksentijevich I, Masters SL, Ferguson PJ, Dancey P, Frenkel J, van Royen-Kerkhoff A, Laxer R, Tedgard U, Cowen EW, Pham TH, Booty M, Estes JD, Sandler NG, Plass N, Stone DL, Turner ML, Hill S, Butman JA, Schneider R, Babyn P, El-Shanti HI, Pope E, Barron K, Bing X, Laurence A, Lee CC, Chapelle D, Clarke GI, Ohson K, Nicholson M, Gadina M, Yang B, Korman BD, Gregersen PK, van Hagen PM, Hak AE, Huizing M, Rahman P, Douek DC, Remmers EF, Kastner DL, Goldbach-Mansky R. An autoinflammatory disease with deficiency of the interleukin-1-receptor antagonist. N Engl J Med. 2009;360:2426-37. This study identified mutations in a key IL-1 pathway gene in children with generalized pustulosis and CRMO-a novel autoinflammatory syndrome named DIRA.
25. •• Reddy S, Jia S, Geoffrey R, Lorier R, Suchi M, Broeckel U, Hessner MJ, Verbsky J. An autoinflammatory disease due to homozygous deletion of the IL1RN locus. N Engl J Med. 2009;360:2438-44. This study also identified mutations in a key IL-1 pathway gene in children with generalized pustulosis and CRMO - A novel autoinflammatory syndrome named DIRA.
26. Edwards TC, Stapleton FB, Bond MJ, Barrett FF. Sweet's syndrome with multifocal sterile osteomyelitis. Am J Dis Child. 1986;140:817-8. (Pubitemid 16033995)
27. Majeed HA, Kalaawi M, Mohanty D, Teebi AS, Tunjekar MF, al-Gharbawy F, Majeed SA, al-Gazzar AH. Congenital dyserythropoietic anemia and chronic recurrent multifocal osteomyelitis in three related children and the association with Sweet syndrome in two siblings. J Pediatr. 1989;115:730-4. (Pubitemid 19270263)
28. Arndt JH. Sweet's syndrome and chronic recurrent multifocal osteomyelitis [letter]. Am J Dis Child. 1987;141:721.
29. Nurre LD, Rabalais GP, Callen JP. Neutrophilic dermatosisassociated sterile chronic multifocal osteomyelitis in pediatric patients: case report and review. Pediatr Dermatol. 1999;16:214-6. (Pubitemid 29270208)
30. Tlougan BE, Podjasek JO, O'Haver J, Cordova KB, Nguyen XH, Tee R, Pinckard-Hansen KC, Hansen RC. Chronic recurrent multifocal osteomyelitis (CRMO) and synovitis, acne, pustulosis, hyperostosis, and osteitis (SAPHO) syndrome with associated neutrophilic dermatoses: a report of seven cases and review of the literature. Pediatr Dermatol. 2009;26:497-505.
31. Majeed HA, Al-Tarawna M, El-Shanti H, Kamel B, Al-Khalaileh F. The syndrome of chronic recurrent multifocal osteomyelitis and congenital dyserythropoietic anaemia. Report of a new family and a review. Eur J Pediatr. 2001;160:705-10. (Pubitemid 33139883)
32. Omidi CJ, Siegfried EC. Chronic recurrent multifocal osteomyelitis preceding pyoderma gangrenosum and occult ulcerative colitis in a pediatric patient. Pediatr Dermatol. 1998;15:435-8. (Pubitemid 29006177)
33. Koturoglu G, Vardar F, Ozkinay F, Kurugol Z, Akalin T, Ozkinay C. Pyoderma gangrenosum in a six-month-old boy. Turk J Pediatr. 2006;48:159-61. (Pubitemid 44070370)
34. Sonozaki H, Mitsui H, Miyanaga Y, Okitsu K, Igarashi M, Hayashi Y, Matsuura M, Azuma A, Okai K, Kawashima M. Clinical features of 53 cases with pustulotic arthro-osteitis. Ann Rheum Dis. 1981;40:547-53. (Pubitemid 12223261)
35. Vittecoq O, Said LA, Michot C, Mejjad O, Thomine JM,Mitrofanoff P, Lechevallier J, Ledosseur P, Gayet A, Lauret P, le Loet X. Evolution of chronic recurrent multifocal osteitis toward spondylarthropathy over the long term. Arthritis Rheum. 2000;43:109-19. (Pubitemid 30368219)
36. Rech J, Manger B, Lang B, Schett G, Wilhelm M, Birkmann J. Adult-onset Still's disease and chronic recurrent multifocal osteomyelitis: a hitherto undescribed manifestation of autoinflammation. Rheumatol Int 2011 [E-published ahead of print]. doi:10.1007/s00296-011-2020-x.
37. Job-Deslandre C, Krebs S, Kahan A. Chronic recurrent multifocal osteomyelitis: five-year outcomes in 14 pediatric cases. Joint Bone Spine. 2001;68:245-51. (Pubitemid 32464006)
38. Kim JE, Kolh EM, Kim DK. Takayasu's arteritis presenting with focal periostitis affecting two limbs. Int J Cardiol. 1998;67:267-70.
39. McConachie NS, Morley KD, Jones MC. Case report: periosteal new bone formation in Takayasu arteritis. Clin Radiol. 1995;50:578-80.
40. Pelkonen P, Ryoppy S, Jaaskelainen J, Rapola J, Repo H, Kaitila I. Chronic osteomyelitislike disease with negative bacterial cultures. Am J Dis Child. 1988;142:1167-73. (Pubitemid 18260786)
41. Kerem E, Manson D, Laxer RM, Levison H, Reilly BJ. Pulmonary association in a case of chronic recurrent multifocal osteomyelitis. Pediatr Pulmonol. 1989;7:55-8.
42. Ravelli A, Marseglia GL, Viola S, Ruperto N, Martini A. Chronic recurrent multifocal osteomyelitis with unusual features. Acta Paediatr. 1995;84:222-5.
43. Majeed SA. Chronic recurrent multifocal osteomyelitis associated with tumoral calcinosis. J Bone Joint Surg Br. 1994;76:325-7. (Pubitemid 24083260)
44. Maus U, Ihme N, Schroeder S, Andereya S, Ohnsorge JA, Hermanns B, Deutz P, Niedhart C. Chronic recurrent multifocal osteomyelitis and tumoral calcinosis-is there an association? Klinische Padiatrie. 2007;219:277-81. (Pubitemid 47450328)
45. Yurdoglu C, Ozbaydar MU, Adas M, Ozger H. Familial tumoral calcinosis in three patients in the same family. Acta Orthopaedica et Traumatologica Turcica. 2007;41:244-8.
46. Ferguson PJ, El-Shanti HI. Autoinflammatory bone disorders. Curr Opin Rheumatol. 2007;19:492-8. (Pubitemid 47344244)
47. Backues KA, Hoover JP, Bahr RJ, Confer AW, Chalman JA, Larry ML. Multifocal pyogranulomatous osteomyelitis resembling chronic recurrent multifocal osteomyelitis in a lemur. J Am Vet Med Assoc. 2001;218:250-3. (Pubitemid 33605386)
48. Ferguson PJ, Bing X, Vasef MA, Ochoa LA, Mahgoub A, Waldschmidt TJ, Tygrett LT, Schlueter AJ, El-Shanti H. A missense mutation in pstpip2 is associated with the murine autoinflammatory disorder chronic multifocal osteomyelitis. Bone. 2006;38:41-7. (Pubitemid 43006073)
49. Grosse J, Chitu V, Marquardt A, Hanke P, Schmittwolf C, Zeitlmann L, Schropp P, Barth B, Yu P, Paffenholz R, Stumm G, Nehls M, Stanley ER. Mutation of mouse Mayp/Pstpip2 causes a macrophage autoinflammatory disease. Blood. 2006;107:3350-8.
50. Safra N, Pedersen NC,Wolf Z, Johnson EG, Liu HW, Hughes AM, Young A, Bannasch DL. Expanded dog leukocyte antigen (DLA) single nucleotide polymorphism (SNP) genotyping reveals spurious class II associations. Veterinary J. 2011;189:220-6.
51. Woodard JC. Canine hypertrophic osteodystrophy, a study of the spontaneous disease in littermates. Veterinary Pathol. 1982;19:337-54. (Pubitemid 12061117)
52. Harrus S, Waner T, Aizenberg, Safra N, Mosenco A, Radoshitsky M, Bark H. Development of hypertrophic osteodystrophy and antibody response in a litter of vaccinated Weimaraner puppies. J Small Anim Pract. 2002;43:27-31. (Pubitemid 135747237)
53. Abeles V, Harrus S, Angles JM, Shalev G, Aizenberg I, Peres Y, Aroch I. Hypertrophic osteodystrophy in six weimaraner puppies associated with systemic signs. Vet Rec. 1999;145:130-4. (Pubitemid 29377942)
54. Golla A, Jansson A, Ramser J, Hellebrand H, Zahn R, Meitinger T, Belohradsky BH, Meindl A. Chronic recurrent multifocal osteomyelitis (CRMO): evidence for a susceptibility gene located on chromosome 18q21.3-18q22. Eur J Hum Genet. 2002;10:217-21. (Pubitemid 34449721)
55. Ben Becher S, Essaddam H, Nahali N, Ben Hamadi F, Mouelhi MH, Hammou A, Hadj Romdhane L, Ben Cheikh M, Boudhina T, Dargouth M. Recurrent multifocal periostosis in children. Report of a familial form. Ann Pediatr (Paris). 1991;38:345-9.
56. Festen JJ, Kuipers FC, Schaars AH. Multifocal recurrent periostitis responsive to colchicine. Scand J Rheumatol. 1985;14:8-14. (Pubitemid 15119207)
57. Hamel J, Paul D, Gahr M, Hedrich CM. Pilot study: possible association of IL10 promoter polymorphisms with CRMO. Rheumatol Int 2011[e-pub ahead of time] doi:10.1007/s00296-010-1768-8.
58. Morbach H, Dick A, Beck C, Stenzel M, Muller-Hermelink HK, Raab P, Girschick HJ. Association of chronic non-bacterial osteomyelitis with Crohn's disease but not with CARD15 gene variants. Rheumatol Int. 2010;30:617-21.
59. Beck C, Girschick HJ, Morbach H, Schwarz T, Yimam T, Frenkel J, van Gijn ME. Mutation screening of the IL-1 receptor antagonist gene in chronic non-bacterial osteomyelitis of childhood and adolescence. Clin. Exp. Rheumatol [e-pub ahead of print], Oct 27, 2011. http://www.ncbi.nlm.nih.gov/pubmed/ 22032624.
60. Majeed HA, El-Shanti H, Al-Rimawi H, Al-Masri N. On mice and men: an autosomal recessive syndrome of chronic recurrent multifocal osteomyelitis and congenital dyserythropoietic anemia. J Pediatr. 2000;137:441-2.
61. Al-Mosawi ZS, Al-Saad KK, Ijadi-Maghsoodi R, El-Shanti HI, Ferguson PJ. A splice site mutation confirms the role of LPIN2 in Majeed syndrome. Arthritis Rheum. 2007;56:960-4. (Pubitemid 46399443)
62. Ferguson PJ, Chen S, Tayeh MK, Ochoa L, Leal SM, Pelet A, Munnich A, Lyonnet S, Majeed HA, El-Shanti H. Homozygous mutations in LPIN2 are responsible for the syndrome of chronic recurrent multifocal osteomyelitis and congenital dyserythropoietic anaemia (Majeed syndrome). J Med Genet. 2005;42:551-7. (Pubitemid 40993830)
63. Donkor J, Sariahmetoglu M, Dewald J, Brindley DN, Reue K. Three mammalian lipins act as phosphatidate phosphatases with distinct tissue expression patterns. J Biol Chem. 2007;282:3450-7. (Pubitemid 47084457)
64. Donkor J, Zhang P, Wong S, O'Loughlin L, Dewald J, Kok BP, Brindley DN, Reue K. A conserved serine residue is required for the phosphatidate phosphatase activity but not transcriptional coactivator functions of lipin-1 and lipin-2. J Biol Chem. 2009;284:29968-78.
65. Peterfy M, Phan J, Xu P, Reue K. Lipodystrophy in the fld mouse results from mutation of a new gene encoding a nuclear protein, lipin. Nat Genet. 2001;27:121-4. (Pubitemid 32044532)
66. Langner CA, Birkenmeier EH, Ben-Zeev O, Schotz MC, Sweet HO, Davisson MT, Gordon JI. The fatty liver dystrophy (fld) mutation. A new mutant mouse with a developmental abnormality in triglyceride metabolism and associated tissue-specific defects in lipoprotein lipase and hepatic lipase activities. J Biol Chem. 1989;264:7994-8003. (Pubitemid 19137280)
67. Reue K, Xu P, Wang XP, Slavin BG. Adipose tissue deficiency, glucose intolerance, and increased atherosclerosis result from mutation in the mouse fatty liver dystrophy (fld) gene. J Lipid Res. 2000;41:1067-76. (Pubitemid 30483010)
68. Reue K, Dwyer JR. Lipin proteins and metabolic homeostasis. J Lipid Res. 2009;50(Suppl):S109-114.
69. •• Reue K. The lipin family: mutations and metabolism. Curr Opin Lipidol. 2009;20:165-70. This is an excellent review of the function of the Lipin proteins.
70. Zeharia A, Shaag A, Houtkooper RH, Hindi T, de Lonlay P, Erez G, Hubert L, Saada A, de Keyzer Y, Eshel G, Vaz FM, Pines O, Elpeleg O. Mutations in LPIN1 cause recurrent acute myoglobinuria in childhood. Amer J Hum Genet. 2008;83:489-94.
71. •• Donkor J, Zhang P, Wong S, O'Loughlin L, Dewald J, Kok BP, Brindley DN, Reue K. A conserved serine residue is required for the phosphatidate phosphatase activity but not the transcriptional coactivator functions of lipin-1 and lipin-2. J Biol Chem. 2009;284:29968-78. This study demonstrated that a Majeed syndrome mutation disrupts PAP activity in Lipin2.
72. Herlin T, Bjerre M, Fiirgaard B, Kerndrup G, Hasle H, Ferguson PJ. Novel mutation of the LPIN2 gene in Majeed syndrome. Response to IL-1 inhibition. Arthritis Rheum 2011;63(10) supplement: S112.
73. Prose NS, Fahrner LJ, Miller CR, Layfield L. Pustular psoriasis with chronic recurrent multifocal osteomyelitis and spontaneous fractures. J Am Acad Dermatol. 1994;31:376-9. (Pubitemid 24249270)
74. • Stenerson M, Dufendach K, Aksentijevich I, Brady J, Austin J, Reed AM. The first reported case of compound heterozygous IL1RN mutations causing deficiency of the interleukin-1 receptor antagonist. Arthritis Rheum. 2011;63:4018-22. This was a report of a child with DIRA and a new mutation in IL1RN carried in a compound heterozygous state.
75. • Jesus AA, Osman M, Silva CA, Kim PW, Pham TH, Gadina M, Yang B, Bertola DR, Carneiro-Sampaio M, Ferguson PJ, Renshaw BR, Schooley K, Brown M, Al-Dosari A, Al-Alami J, Sims JE, Goldbach-Mansky R, El-Shanti H. A novel mutation of IL1RN in the deficiency of interleukin-1 receptor antagonist syndrome: description of two unrelated cases from Brazil. Arthritis Rheum. 2011;63:4007-17. This study reported the clinical manifestations and genetic defects in two infants with DIRA.
76. •• Marrakchi S, Guigue P, Renshaw BR, Puel A, Pei XY, Fraitag S, Zribi J, Bal E, Cluzeau C, Chrabieh M, Towne JE, Douangpanya J, Pons C, Mansour S, Serre V, Makni H, Mahfoudh N, Fakhfakh F, Bodemer C, Feingold J, Hadj-Rabia S, Favre M, Genin E, Sahbatou M, Munnich A, Casanova JL, Sims JE, Turki H, Bachelez H, Smahi A. Interleukin-36-receptor antagonist deficiency and generalized pustular psoriasis. N Engl J Med. 2011;365:620-8. This study identified a gene defect in the IL36 receptor antagonist gene causing generalized pustulosis without bone inflammation.
77. Goldbach-Mansky R. Current status of understanding the pathogenesis and management of patients with NOMID/CINCA. Curr Rheumatol Reports. 2011;13:123-31.
78. • Twilt M, Laxer RM. Clinical care of children with sterile bone inflammation. Curr Opin Rheumatol. 2011;23:424-31. This is an excellent review of treatment of CRMO.
79. •• Beck C, Morbach H, Beer M, Stenzel M, Tappe D, Gattenlohner S, Hofmann U, Raab P, Girschick HJ. Chronic nonbacterial osteomyelitis in childhood: prospective follow-up during the first year of anti-inflammatory treatment. Arthritis Res Ther. 2010;12:R74. This was the first prospective study of response to NSAIDs in CRMO.
80. • Miettunen PM, Wei X, Kaura D, Reslan WA, Aguirre AN, Kellner JD. Dramatic pain relief and resolution of bone inflammation following pamidronate in 9 pediatric patients with persistent chronic recurrent multifocal osteomyelitis (CRMO). Pediatr Rheumatol Online J. 2009;7:2. This is a prospective analysis of response to bisophosphonates in nine children with CRMO.
81. • Eleftheriou D, Gerschman T, Sebire N, Woo P, Pilkington CA, Brogan PA. Biologic therapy in refractory chronic non-bacterial osteomyelitis of childhood. Rheumatol. 2010;49:1505-12. This is a summary of response to treatment in children with CRMO treated with biologic agents.
82. Marangoni RG, Halpern AS. Chronic recurrent multifocal osteomyelitis primarily affecting the spine treated with anti-TNF therapy. Spine. 2010;35:E253-256.
83. Simm PJ, Allen RC, Zacharin MR. Bisphosphonate treatment in chronic recurrent multifocal osteomyelitis. J Pediatr. 2008;152:571-5. (Pubitemid 351381031)
84. Hospach T, Langendoerfer M, von Kalle T, Maier J, Dannecker GE. Spinal involvement in chronic recurrent multifocal osteomyelitis (CRMO) in childhood and effect of pamidronate. European J Pediatr. 2010;169:1105-11.
85. Compeyrot-Lacassagne S, Rosenberg AM, Babyn P, Laxer RM. Pamidronate treatment of chronic noninfectious inflammatory lesions of the mandible in children. J Rheumatol. 2007;34:1585-9. (Pubitemid 47068000)
86. De Cunto A, Maschio M, Lepore L, Zennaro F. A case of chronic recurrent multifocal osteomyelitis successfully treated with neridronate. J Pediatr. 2009;154:154-5.
87. Yamazaki Y, Satoh C, Ishikawa M, Notani K, Nomura K, Kitagawa Y. Remarkable response of juvenile diffuse sclerosing osteomyelitis of mandible to pamidronate. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2007;104:67-71.
88. Kerrison C, Davidson JE, Cleary AG, Beresford MW. Pamidronate in the treatment of childhood SAPHO syndrome. Rheumatol (Oxford). 2004;43:1246-51. (Pubitemid 39359298)
89. Kuijpers SC, de Jong E, Hamdy NA, van Merkesteyn JP. Initial results of the treatment of diffuse sclerosing osteomyelitis of the mandible with bisphosphonates. J Craniomaxillofac Surg. 2011;39:65-8.
90. Gleeson H, Wiltshire E, Briody J, Hall J, Chaitow J, Sillence D, Cowell C, Munns C. Childhood chronic recurrent multifocal osteomyelitis: pamidronate therapy decreases pain and improves vertebral shape. J Rheumatol. 2008;35:707-12. (Pubitemid 351500071)
91. Aktay Ayaz N, Topaloglu R, Ozaltin F, Caglar TuncaliM, Bakkaloglu A. A case of chronic recurrent multifocal osteomyelitis successfully treated with etanercept. Pediatr Rheumatol 2008; 6(S1): 191. doi:10.1186/1546-0096-6-S1-P191.
92. Eisenstein EM, Syverson GD, Vora SS, Williams CB. Combination therapy with methotrexate and etanercept for refractory chronic recurrent multifocal osteomyelitis. J Rheumatol. 2011;38:782-3.
93. Deutschmann A, Mache CJ, Bodo K, Zebedin D, Ring E. Successful treatment of chronic recurrent multifocal osteomyelitis with tumor necrosis factor-alpha blockage. Pediatr. 2005;116:1231-3. (Pubitemid 46056433)
94. Wolber C, David-Jelinek K, Udvardi A, Artacker G, Volc-Platzer B, Kurz H. Successful therapy of sacroiliitis in SAPHO syndrome by etanercept. WienermedizinischeWochenschrift. 2011;161:204-8.
95. Coloe J, Diamantis S, Henderson F, Morrell DS. Synovitis-acnepustulosis- hyperostosis-osteitis (SAPHO) syndrome complicated by seven pulmonary emboli in a 15-year old patient. J Amer Acad Dermatol. 2010;62:333-6.
96. Stern S, Marzan K, Borzutzky A, Steinberg E, Reiff A. Use of TNF antagonists in the treatment of chronic non-bacterial osteomyelitis (CNO). Arthritis Rheum 2010;62(10)supplement: S101.
97. Colina M, Pizzirani C, Khodeir M, Falzoni S, Bruschi M, Trotta F, Di Virgilio F. Dysregulation of P2X7 receptor-inflammasome axis in SAPHO syndrome: successful treatment with anakinra. Rheumatol. 2010;49:1416-8.